Ingredient Dictionary/acrylates-c10-30-alkyl-acrylate-crosspolymer/ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
Synthetic

ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER

Film FormingViscosity ControllingEmulsion Stabilizer
[EU CosIng Official Definition] C10-30 alkyl propenoate, polymer with propenoic acid, butenoic acidand/or alkyl propenoates, product with propenyl sucrose ether or propenyl 2,2-dihydroxymethyl-1,3-propanediol
Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

What is ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (CAS N/A) in cosmetics and what are its global regulatory limits?

ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (CAS No. N/A) is a verified cosmetic ingredient primarily functioning as Film Forming, Viscosity Controlling, Emulsion Stabilizer in topical formulations. Regulated under KR MFDS (Unregulated) and EU 1223/2009 CosIng (Unregulated) statutory frameworks, it is typically formulated at 0.1–0.8% within an optimal stability window of pH 5–9.

7-Track Official Regulatory Label Names Matrix

Primary Statutory Gazette Only · Zero Machine Translation
7-Track Official Statutory Label Names for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
Jurisdiction TrackOfficial Statutory Label NameOne-Click Copy
1. Korea (MFDS Standard Name)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (KR MFDS Registered)
2. Korea Former Nomenclature History——
3. European Union (EU CosIng Glossary)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
4. United States (US PCPC / MoCRA INCI)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
5. US FDA OTC Monograph Active Name— (Cosmetic Inactive / Non-OTC)—
6. China (NMPA IECIC Standard Name)丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物
7. Japan (JCIA Standard / MHLW Quasi-Drug)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (Standard INCI Reference)

Layer 1 — Statutory Regulatory Limits Across 6 Regions

Layer 1 Statutory Regulatory Limits Across 6 Regions for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
RegionStatusMax LimitConditions & Statutory Source
Korea (MFDS)UnregulatedGMPListed in official cosmetic inventory
Europe (EU)UnregulatedGMPListed in official cosmetic inventory
United States (FDA)UnregulatedGMPListed in official cosmetic inventory
China (NMPA)UnregulatedGMPIECIC Entry #1423
Japan (MHLW)UnregulatedGMPListed in official cosmetic inventory
ASEAN (ACD)UnregulatedGMPListed in official cosmetic inventory

Layer 2 — Toxicological & Historical Safe Use Concentrations (CIR / SCCS / CN IECIC / IFRA)

“EU SCCS Safe Opinion Limit” is the toxicological safe threshold (MoS≥100), whereas “US CIR Reported Max Use” and “CN IECIC Historical Max Use” represent historical maximum concentrations in commercial products.

Layer 2 Toxicological & Historical Safe Use Concentrations for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
Assessment BasisApplication ScopeConcentration RangeVerdict & Dossier Reference
CN IECIC Historical Max Useleave_on≤ 2.6%Safe (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025)
CN IECIC Historical Max Userinse_off≤ 2%Safe (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025)
⚠️ Reference Only (Legal Disclaimer): The regulatory limits, ingredient names, and formulation ranges in this dictionary are provided for R&D reference only. Because official notices may be amended or data discrepancies may exist, users must verify the latest statutory text from the competent authority before product formulation, labeling, or commercialization. UNIZ LAB assumes no legal liability for the use of this information.
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Aqueous Serum / Ampoulen=45
Min 0.1% · Q1 0.15% · Median 0.25% · Q3 0.35% · Max 0.8%
Emulsion / Creamn=118
Min 0.1% · Q1 0.15% · Median 0.2% · Q3 0.3% · Max 0.8%
Sunscreen / Colorn=10
Min 0.15% · Q1 0.2% · Median 0.25% · Q3 7.6% · Max 20%
Aqueous Serum / Ampoule — Hydrogel thickener & polymeric co-emulsifier
Verified Source: Lubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment (cir_safety) · Lubrizol 24 · Evonik 14 · Colonial 7
Typical Median: 0.25%

Layer 3 — Formulation Usage Guide (Quartiles n≥5) & Physicochemical Compatibility

Layer 3 Formulation Concentration Quartiles by Product Category for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
Formulation GroupMin – Q1 – Median – Q3 – Max (%)Role & MechanismSource ID
Group A — Aqueous Toner / Serum / Ampoule0.1% · 0.15% · 0.25% · 0.35% · 0.8%Hydrogel thickener & polymeric co-emulsifierLubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment
Group B — O/W & W/O Emulsion / Lotion / Cream0.1% · 0.15% · 0.2% · 0.3% · 0.8%Surfactant-free polymeric primary/co-emulsifierLubrizol Pemulen TDS & CIR Reported Use
Group D — Sunscreen (UV) / Color Cosmetics / Foundation0.15% · 0.2% · 0.25% · 7.6% · 20%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=10, EVONIK 8 · GRANT 2)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Dispersible in water or oil phase prior to neutralization
Optimal Formulation pH Stability Window (0–14)pH 5.0 – 9.0
0245.5791114

Outside pH 5–9, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 80°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 80°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ TROMETHAMINE+ ARGININE+ CAPRYLIC/CAPRIC TR…✕ Viscosity loss at pH…✕ Incompatible with ca…ACRYLATES/C10-30 A…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

Nominative Trade Name References (Trademark Act Art. 90(1)(2))
Pemulen™ TR-1Pemulen™ TR-2Carbopol® Ultrez 20Carbopol® Ultrez 30

Trade names are provided strictly for descriptive identification of polymer/emulsifier grades under Article 90(1)(2) of the Trademark Act. All trademarks belong to their respective owners.

Academic & Toxicological Synthesis

Tier 1 Synthesis

Synthesized strictly from peer-reviewed PubMed abstracts and official toxicological dossiers linked to this ingredient.

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER | CAS No.: N/A | EC No.: N/A - Origin: SYNTHETIC | Functions: , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: anionic | CosIng/MFDS - Official Regional Label Names: US [ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER] · EU [ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER] · CN [丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - C10-30 alkyl propenoate, polymer with propenoic acid, butenoic acidand/or alkyl propenoates, product with propenyl sucrose ether or propenyl 2,2-dihydroxymethyl-1,3-propanediol Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: NONE | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 1423 (丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): CN_IECIC_2025 (cn_iecic_max, leave_on): Max 2.6% / CN_IECIC_2025 (cn_iecic_max, rinse_off): Max 2.0% ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [aqueous_serum] Typical range: 0.1 ~ 0.8% (Median 0.25%, Ref: Lubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment) — Hydrogel thickener & polymeric co-emulsifier - [emulsion_cream] Typical range: 0.1 ~ 0.8% (Median 0.2%, Ref: Lubrizol Pemulen TDS & CIR Reported Use) — Surfactant-free polymeric primary/co-emulsifier - [sun_color] Typical range: 0.15 ~ 20.0% (Median 0.25%, Ref: Global Starter Formulation Library Statistical Distribution (n=10, EVONIK 8 · GRANT 2)) — Sun care & color cosmetics dispersion / sensory modifier ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water or Oil Phase (Direct addition prior to neutralization) - Optimal pH Range: pH 5.0 ~ 9.0 | Max Process Temp: Max 80°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Viscosity loss at pH < 4.5 or high multivalent electrolyte levels - Incompatibility / Caution: Incompatible with cationic conditioning agents - Synergy Pairings: TROMETHAMINE, ARGININE, CAPRYLIC/CAPRIC TRIGLYCERIDE | Reference Trade Names: Pemulen™ TR-1, Pemulen™ TR-2, Carbopol® Ultrez 20, Carbopol® Ultrez 30 ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 39187930 (2024, Contact Dermatitis): Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C - PMID 24575934 (2014, Int J Cosmet Sci): Texture analysis of cosmetic/pharmaceutical raw materials and formulations - PMID 19398245 (2009, Am J Infect Control): Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels

Linked Peer-Reviewed Literature (NIH PubMed) (3)

Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rare [PMID: 39187930 · 2024]
Soriano LF, Chowdhury MMU, Cousen P, Dawe S, Ghaffar SA, Haworth A, Holden CR, Hollywood A, Johnston GA, Kirk S, Mughal AA, Orton DI, Parker R, Rajeev A, Scharrer K, Sinha A, Stone NM, Thompson D, Wakelin S, Whitehouse H, Wootton C, Buckley DA · Contact Dermatitis (2024)

Acrylate polymers and cross-polymers (ACPs) are frequently used cosmetic ingredients. The British Society for Cutaneous Allergy (BSCA) and the UK Cosmetic, Toiletry and Perfumery Association (CTPA) collaborated to investigate the allergenic potential of three commonly-used ACPs. The objective of this study is to determine the prevalence of allergic contact dermatitis (ACD) to three ACPs: glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate, and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol&#xae;). The BSCA prospectively audited data collected from 20 centres in the UK and Ireland between 1st September 2021 and 1st September 2022. Patients with suspected ACD to (meth)acrylates, with facial dermatitis, or consecutive patients, were patch tested to glyceryl acrylate/acrylic acid co-polymer 10% aqueous (aq.) sodium polyacrylate 2% aq., and to acrylates/C10-30 alkyl acrylate cross-polymer 2% aq. (Carbopol&#xae;). The frequencies of positive, irritant, and doubtful reactions were recorded. In total, 1302 patients were patch tested. To glyceryl acrylate/acrylic acid co-polymer, there was one doubtful reaction in a patient allergic to multiple (meth)acrylates, and one irritant. To sodium polyacrylate, there were four irritant reactions, one doubtful, and one positive reaction; in all cases, relevance was unknown and there was no demonstrable (meth)acrylate allergy. There were no reactions to Carbopol&#xae;. Sensitisation to these concentrations of the three tested ACPs is rare. Elicitation of dermatitis in (meth)acrylate-sensitised patients by exposure to these three ACPs appears unlikely.

Texture analysis of cosmetic/pharmaceutical raw materials and formulations [PMID: 24575934 · 2014]
Tai A, Bianchini R, Jachowicz J · Int J Cosmet Sci (2014)

The purpose of this work was to quantify textural properties of cosmetic and pharmaceutical raw materials. Textural parameters such as hardness, consistency, cohesiveness, index of viscosity, stickiness and resilience were evaluated. The measurements were performed using texture analyser - a tensile metre equipped with special probes (in the form of acrylic cylinder and stainless steel sphere), which can penetrate the measured sample of a product recording the force, distance and time. The instrument simulates the action of a human finger touching the surface and probing the properties of an object. The set-up has been previously shown to quantify the rheological/textural properties of cosmetic and pharmaceutical products such as creams, lotion and gels as well as rheological behaviour of human skin. The results include the analysis of water, glycerine and mineral oil as well as aqueous solutions of thickeners such as Acrylates/C10-30 Alkyl Acrylate Crosspolymer (Ultrez-20 obtained from Noveon) and carbomer. Solutions of common surfactants and complex surfactant formulations such as shampoos have also been investigated. The results, in the form plots of force as a function of time or distance, resulting from slow bidirectional probe movement (submergence and desubmergence) in the analysed fluid, were interpreted by considering buoyancy, drag and viscous drag force given by Stokes equation. The data can be used to correlate with tactile evaluations of products by trained panel evaluations.

Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels [PMID: 19398245 · 2009]
Kaiser N, Klein D, Karanja P, Greten Z, Newman J · Am J Infect Control (2009)

Incompatibility of leave-on products with an antimicrobial residual can negate the efficacy benefits of chlorhexidine gluconate (CHG) persistence. Two marketed alcohol products containing Carbomer were tested using a pigskin substrate model against Staphylococcus aureus. The CHG residual achieved a 4.22 log(10) reduction (standard deviation [SD] = 0.32) in this study, which was dramatically reduced to a 0.54 (SD = 0.50) and 0.46 (SD = 0.56) after subsequent treatment with incompatible alcohol gel products. A marketed alcohol product containing a nonionic thickener maintained the efficacy of the CHG chemical reservoir (log(10) reduction = 4.26, SD = 0.00). Similar findings were demonstrated when alcohol solutions containing the individual thickening agents were tested as simple formulations. An in vivo test using human forearms and Serratia marcescens similarly demonstrated that the activity of a CHG reservoir (log(10) reduction = 3.73, SD = 0.86) was not reduced by a nonionic thickened product (log(10) reduction = 3.98, SD = 0.72) but was significantly reduced by treatment with alcohol products containing anionic thickeners carbomer (log(10) reduction = -0.32, SD = 0.34) or acrylates/C10-30 alkyl acrylate crosspolymer (log(10) reduction = -0.20, SD = 0.32). The use of anionic thickeners or emulsifiers in leave-on products, including alcohol hand sanitizers, may inactivate the persistent antibacterial activity of CHG.

Frequently Asked Questions (AEO Position 0)

Q1. What are the official 7-track regulatory label names for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
Standard label names are US PCPC INCI: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER', EU CosIng: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER', KR MFDS: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (KR MFDS Registered)', CN NMPA IECIC: '丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物', and JP JCIA: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER'.
Q2. Is ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER restricted or permitted in EU, US, KR, CN, and JP cosmetics?
Regulatory status summary across 6 jurisdictions — KR: none, EU: none, US: none, CN: none, JP: none, ASEAN: none.
Q3. What is the typical formulation concentration and optimal pH window for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
In aqueous_serum systems, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER is typically formulated between 0.1% and 0.8% (median 0.25%), with an optimal stability window of pH 5–9.
Q4. What are the known formulation incompatibilities and synergy pairings for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
Recommended synergy pairings include TROMETHAMINE, ARGININE, CAPRYLIC/CAPRIC TRIGLYCERIDE. Key incompatibilities to avoid: Viscosity loss at pH < 4.5 or high multivalent electrolyte levels; Incompatible with cationic conditioning agents.